ESMO 2022 Conference Coverage


 

ESMO 2022 on the Results of the Randomized DICIPLE Phase 3 Trial: Nivo + Ipi 6-Month Treatment vs. Continuation in Advanced NSCLC

1,093 views
September 15, 2022
Comments 0
Login to view comments. Click here to Login